Manuel Pombo‐Suárez

Author

Manuel Pombo‐Suárez

Complejo Hospitalario Universitario de Santiago ORCID

Also Known As

M Pombo-Suarez, M. Pombo-Suarez, Manuel Pombo-Suarez, Manuel Pombo-Suárez, Manuel Pombo‐Suarez, Manuel Pombo‐Suárez, Pombo-Suarez, M

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Complejo Hospitalario Universitario de Santiago Diakonhjemmet Hospital University of Bari Aldo Moro Ljubljana University Medical Centre Helsinki University Hospital

About

Manuel Pombo‐Suárez is an author at Complejo Hospitalario Universitario de Santiago specializing in rheumatology, medicine, and cartilage degeneration.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	84
2	Rheumatology	2	2	84
3	Orthopaedics	1	1	68
4	Pathology	1	1	68
5	Cartilage Degeneration	1	1	68

Manuel Pombo‐Suárez

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
An SNP in the 5′-UTR of GDF5 is associated with osteoarthritis susceptibility in Europeans and with in vivo differences in allelic expression in articular cartilage Lorraine Southam, Julio A. Rodriguez‐Lopez, James M. Wilkins, Human Molecular Genetics	2007	216
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration Kim Lauper, Michele Iudici, Denis Mongin, Annals of the Rheumatic Diseases	2022	138
Functional analysis of the osteoarthritis susceptibility–associated <i>GDF5</i> regulatory polymorphism Rainer J. Egli, Lorraine Southam, James M. Wilkins, Arthritis & Rheumatism	2009	132
Reference genes for normalization of gene expression studies in human osteoarthritic articular cartilage Manuel Pombo‐Suárez, Manuel Calaza, Juan J. Gómez‐Reino, BMC Molecular Biology	2008	89
Lack of association of a variable number of aspartic acid residues in the asporin gene with osteoarthritis susceptibility: case-control studies in Spanish Caucasians Julio A. Rodriguez‐Lopez, Manuel Pombo‐Suárez, Myriam Liz, Arthritis Research & Therapy	2006	68
Association of a nsSNP in ADAMTS14 to some osteoarthritis phenotypes Julio A. Rodriguez‐Lopez, Manuel Pombo‐Suárez, John Loughlin, Osteoarthritis and Cartilage RheumatologyMusculoskeletal ResearchGeneticsGenetic EpidemiologyCartilage Degeneration	2008	68
Tolerability, Safety, and Quality of Life with Tapentadol Prolonged Release (<scp>PR</scp>) Compared with Oxycodone/Naloxone <scp>PR</scp> in Patients with Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open‐label, Phase 3b/4 Trial Ralf Baron, Jan‐Peter Jansen, Andreas Binder, Pain Practice	2015	67
Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration Brigitte Michelsen, Ulf Lindström, Cătălin Codreanu, RMD Open	2020	61
Further evidence of the role of frizzled-related protein gene polymorphisms in osteoarthritis Julio A. Rodriguez‐Lopez, Manuel Pombo‐Suárez, Myriam Liz, Annals of the Rheumatic Diseases	2007	58
Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety John D. Markman, Robert Bolash, Timothy E. McAlindon, Pain	2020	54

Page 1